|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 October 2017 |
|
Main ID: |
NCT02597582 |
|
Date of registration:
|
03/11/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients
|
|
Scientific title:
|
A Prospective Randomized Study of LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients |
|
Date of first enrolment:
|
January 2014 |
|
Target sample size:
|
41 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT02597582 |
|
Study type:
|
Interventional |
|
Study design:
|
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Taiwan
| | | | | | | |
|
Contacts
|
|
Name:
|
Shih-An Liu, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Taichung Veterans General Hospital |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients aged 20 to 80 years scheduled to receive neck dissection due to head and neck
cancer
Exclusion Criteria:
- history of coagulation disorders
- prior radiation to the neck
- prior neck dissection
- declined to participate
Age minimum:
20 Years
Age maximum:
80 Years
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Head and Neck Neoplasms
|
|
Intervention(s)
|
|
Procedure: Neck dissection
|
|
Primary Outcome(s)
|
|
Opreation Duration
[Time Frame: 1 day]
|
|
Secondary Outcome(s)
|
|
Postoperative Oral Analgesic Consumption
[Time Frame: 2 weeks]
|
|
Postoperative Drainage Amount
[Time Frame: 2 weeks]
|
|
Postoperative Injected Analgesic Amount
[Time Frame: 2 weeks]
|
|
Intraoperative Blood Loss
[Time Frame: 1 day]
|
|
Postoperative Subjective Pain Status
[Time Frame: 2 weeks]
|
|
Secondary ID(s)
|
|
TCVGH-1037004C
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|